Imugene RMT move

Imugene RMT move IMUGENE has announced commercial development plans for its first receptor mimic technology product.The first product will be used to treat colibacillosis in pigs, a disease caused by


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
50 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer